CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 32 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $77,000 | +102.6% | 9,242 | +66.4% | 0.00% | – |
| Q4 2021 | $38,000 | -73.4% | 5,553 | -79.5% | 0.00% | – |
| Q3 2021 | $143,000 | -76.4% | 27,056 | -74.3% | 0.00% | -100.0% |
| Q2 2021 | $605,000 | -22.1% | 105,248 | -47.8% | 0.00% | -83.3% |
| Q1 2020 | $777,000 | +26.3% | 201,698 | +23.1% | 0.01% | +50.0% |
| Q4 2019 | $615,000 | -38.0% | 163,903 | -12.3% | 0.00% | -50.0% |
| Q3 2019 | $992,000 | +593.7% | 186,798 | +402.0% | 0.01% | +700.0% |
| Q2 2019 | $143,000 | +346.9% | 37,212 | +122.0% | 0.00% | – |
| Q4 2018 | $32,000 | -40.7% | 16,764 | +17.2% | 0.00% | – |
| Q3 2018 | $54,000 | +42.1% | 14,306 | +17.0% | 0.00% | – |
| Q2 2018 | $38,000 | +660.0% | 12,224 | +515.8% | 0.00% | – |
| Q1 2018 | $5,000 | -16.7% | 1,985 | +26.1% | 0.00% | – |
| Q4 2017 | $6,000 | 0.0% | 1,574 | -38.3% | 0.00% | – |
| Q3 2017 | $6,000 | +50.0% | 2,553 | +82.6% | 0.00% | – |
| Q3 2015 | $4,000 | -93.9% | 1,398 | -94.7% | 0.00% | -100.0% |
| Q2 2014 | $66,000 | +127.6% | 26,248 | +107.1% | 0.00% | – |
| Q1 2014 | $29,000 | +16.0% | 12,676 | -1.7% | 0.00% | – |
| Q4 2013 | $25,000 | – | 12,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 213,609 | $1,446,000 | 2.75% |
| GABLES CAPITAL MANAGEMENT INC. | 449,164 | $3,041,000 | 1.81% |
| Prairiewood Capital, LLC | 261,403 | $1,770,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 9,572,000 | $64,802,000 | 1.06% |
| Quantedge Capital Pte Ltd | 360,100 | $2,438,000 | 1.03% |
| SummerHaven Investment Management, LLC | 151,384 | $1,025,000 | 0.55% |
| GLOBEFLEX CAPITAL L P | 609,030 | $4,124,000 | 0.42% |
| EAM Global Investors LLC | 347,899 | $2,355,000 | 0.42% |
| Lanham O'Dell & Company, Inc. | 50,000 | $339,000 | 0.27% |
| EAM Investors, LLC | 239,071 | $1,619,000 | 0.27% |